REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 166 filers reported holding REGENXBIO INC in Q3 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $406,397 | -42.9% | 24,690 | -30.6% | 0.00% | 0.0% |
| Q2 2023 | $711,244 | -33.8% | 35,580 | -37.4% | 0.00% | -50.0% |
| Q1 2023 | $1,074,731 | +60.7% | 56,834 | +92.7% | 0.00% | +100.0% |
| Q4 2022 | $668,969 | -99.9% | 29,496 | -41.4% | 0.00% | -50.0% |
| Q3 2022 | $1,330,301,000 | +406.7% | 50,333 | +373.5% | 0.00% | – |
| Q2 2022 | $262,561,000 | -28.6% | 10,630 | -4.0% | 0.00% | – |
| Q1 2022 | $367,546,000 | -43.7% | 11,074 | -44.5% | 0.00% | -100.0% |
| Q4 2021 | $652,659,000 | -58.6% | 19,959 | -46.9% | 0.00% | -50.0% |
| Q3 2021 | $1,576,737,000 | +226.1% | 37,613 | +202.2% | 0.00% | +100.0% |
| Q2 2021 | $483,527,000 | +29.9% | 12,446 | +14.0% | 0.00% | 0.0% |
| Q1 2021 | $372,345,000 | -87.2% | 10,916 | -83.0% | 0.00% | -80.0% |
| Q4 2020 | $2,916,966,000 | +191.0% | 64,307 | +76.6% | 0.01% | +400.0% |
| Q3 2020 | $1,002,306,000 | -72.4% | 36,421 | -63.1% | 0.00% | -83.3% |
| Q2 2020 | $3,630,775,000 | -7.9% | 98,582 | -19.0% | 0.01% | -25.0% |
| Q1 2020 | $3,942,621,000 | -14.7% | 121,761 | +7.9% | 0.01% | 0.0% |
| Q4 2019 | $4,622,891,000 | +2070.8% | 112,836 | +1786.3% | 0.01% | – |
| Q3 2019 | $212,959,000 | -5.6% | 5,982 | +36.2% | 0.00% | – |
| Q2 2019 | $225,668,000 | -47.4% | 4,393 | -41.3% | 0.00% | -100.0% |
| Q1 2019 | $429,080,000 | +624.9% | 7,487 | +430.6% | 0.00% | – |
| Q4 2018 | $59,191,000 | -61.9% | 1,411 | -31.5% | 0.00% | – |
| Q3 2018 | $155,530,000 | +24.7% | 2,060 | +18.5% | 0.00% | – |
| Q2 2018 | $124,702,000 | -28.9% | 1,738 | -70.4% | 0.00% | – |
| Q1 2018 | $175,279,000 | -6.0% | 5,872 | +4.7% | 0.00% | – |
| Q4 2017 | $186,566,000 | +151.8% | 5,611 | +149.5% | 0.00% | – |
| Q3 2017 | $74,105,000 | +31.5% | 2,249 | -21.2% | 0.00% | – |
| Q2 2017 | $56,347,000 | +251.8% | 2,853 | +243.7% | 0.00% | – |
| Q1 2017 | $16,019,000 | +205.1% | 830 | +193.3% | 0.00% | – |
| Q4 2016 | $5,250,000 | -75.0% | 283 | -81.1% | 0.00% | – |
| Q3 2016 | $21,029,000 | +232.7% | 1,501 | +90.0% | 0.00% | – |
| Q2 2016 | $6,320,000 | +1120.1% | 790 | +1545.8% | 0.00% | – |
| Q1 2016 | $518,000 | -97.6% | 48 | -96.4% | 0.00% | – |
| Q4 2015 | $21,846,000 | – | 1,316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |